Invokana Side Effects Are Front and Center in Lawsuit Claiming Drug Caused Development Of Diabetic Ketoacidosis

April 26, 2016 – – TheProductLawyers.com comments on a lawsuit filed by a diabetes patient who has stated in court documents that she began taking Invokana, a new-generation, type 2 diabetes drug, in December 2014. Shortly thereafter she alleges in her filing to the court that she developed a potentially life-threatening condition known as diabetic ketoacidosis. Upon further review of the plaintiff’s court filing, she claims that she was never made aware of this potentially very debilitating risk and that the drug’s manufacturer, Janssen Pharmaceuticals (Johnson & Johnson) was negligent in not revealing this particular side effect as a possible consequence of use of the drug.

Diabetic ketoacidosis is a very serious medical condition that can precipitate a diabetic coma or even death in some extreme cases. According to the American Diabetes Association, the body will begin to burn stored fat for energy when there is no glucose available. The result of this process is the production of ketones. An excess amount of ketones in the bloodstream will cause the blood to become acidic, sometimes in as little as 24 hours, and make the patient very sick.

The U.S. Food and Drug Administration (FDA) cited this potential concern in a public safety warning and discussed the possible link between Invokana and the development of diabetic ketoacidosis. It also indicated that patients who use Invokana or other similar SGLT2 class inhibitor drugs should remain on guard for any potential signs of the development of diabetic ketoacidosis which, according to The Mayo Clinic, includes abdominal pain, nausea and vomiting, confusion, frequent urination, and excessive thirst.

The FDA has also mandated that Janssen make all applicable and appropriate changes to the product’s warning label in order to provide a better clarification of the potential side effects for patients considering the use of Invokana or similar SGLT2 inhibitor drugs.

For more information about the Invokana lawsuits, or this press release, please contact TheProductLawyers.com on 888-997-3792.

###

Contact TheProductLawyers.com:

Banville Law
888-997-3792
info@banvillelaw.com
165 West End Ave #1h,
New York, NY 10023

ReleaseID: 60009581